Manufacturer:

Bristol Myers Squibb

Name:

OPDUALAG

Category:

J Code

HCPCS:

J9298

NDC(s):

00003-7125-11,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

OPDUALAG is a Cancer drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J9298 is aligned to the drug OPDUALAG.

Opdualag belongs to the group of drugs known as antineoplastic combinations and is used to treat certain types of cancer. This drug is a combination two different medications known as nivolumab and relatlimab. Opdualag is administered to the patient via intravenous infusion over the course of 30 minutes. Opdualag is a branded drug manufactured by the Bristol-Myers Squibb Company. Patient assistance programs for Opdualag can be found through Bristol-Myers Squibb’s Access Support here https://www.bmsaccesssupport.bmscustomerconnect.com/patient.